Search | IOVS | ARVO Journals

Showing 1 – 20 of 20

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

A Pilot Study to Evaluate Surgical Implantation of a Protein-Based Artificial Retina in a Rodent

Nicole Wagner; Jordan Greco; David Culp; Justin Prater; Brian Gilger

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3942. doi:

ARVO Annual Meeting Abstract July 2019

Characterization of a Chronic Panuveitis Model in the Rabbit.

David Culp; Justin Prater; Adam Moser; Brian C Gilger

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):801. doi:

ARVO Annual Meeting Abstract July 2019

Chronic Model of Retinal Neovascularization (RNV) in New Zealand Red Rabbits.

M. Grazia Spiga; Brian C Gilger; David Culp

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2568. doi:

ARVO Annual Meeting Abstract July 2019

Characterization of the Royal College of Surgeon’s Rat Model Endpoints for Use in Preclinical Ophthalmic Studies

Justin Prater; Vicky Peele; David Culp; Brian C Gilger

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):203. doi:

ARVO Annual Meeting Abstract July 2018

Sunitinib-Loaded Injectable Polymer Depot Formulation for Potential Once per Year Treatment of Neovascular Age-related Macular Degeneration (wet AMD)

Yun Yu; Ward Peterson; Ming Yang; David McKenzie; Delia Cardona; David Culp; Brian C Gilger; Jeffrey Cleland

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):221. doi:

ARVO Annual Meeting Abstract July 2018

Activity of anti-Tissue Factor fusion protein ICON-1 in a swine model of choroidal neovascularization

William Greene; Grazia Spiga; Brian C Gilger; David Culp; Thi-Sau Migone

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):225. doi:

ARVO Annual Meeting Abstract July 2018

ICON-1 Pharmacokinetics after intravitreal and intravenous administration to rabbits

Gabriela Burian; Jacques Gaudreault; Brian C Gilger; David Culp; Thi-Sau Migone

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):231. doi:

ARVO Annual Meeting Abstract July 2018

Assessment of a pre-clinical model of phacoemulsification and aspiration of cataracts in rabbits

Justin Prater; David Culp; Grazia Spiga; Damian Launer; Brian C Gilger

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2239. doi:

ARVO Annual Meeting Abstract July 2018

Episcleral sustained ocular delivery of bromfenac and brinzolamide

Jacklyn H Salmon; Santhi Abbaraju; Shadia Hanna; Lee Hamm; Rasidul Amin; David Culp; Brian C Gilger

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5687. doi:

ARVO Annual Meeting Abstract July 2018

Characterization of a quantitative model of corneal transplantation in the rabbit

David Culp; Grazia Spiga; Justin Prater; Brian C Gilger

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4370. doi:

ARVO Annual Meeting Abstract June 2017

Effect of ST266, an amnion-derived multipotent progenitor cell-derived secretome, in a corneal incision model for post-operative inflammation

Howard Wessel; Elise Gill; Erika Klitsch; Kenneth J Mandell; David Culp; Justin Prater; Brian C Gilger; Larry Brown

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):137. doi:

ARVO Annual Meeting Abstract June 2017

Anti-inflammatory effects of ST266, an amnion-derived multipotent progenitor cell-derived secretome, on corneal wound healing and stromal fibrosis in rabbits

Larry Brown; Howard Wessel; Erika Klitsch; Elise Gill; Justin Prater; David Culp; Brian C Gilger; Kenneth J Mandell

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2644. doi:

ARVO Annual Meeting Abstract June 2017

Anti-allergic effects of ST266, an amnion-derived multipotent progenitor cell-secretome, in ovalbumin-induced allergic conjunctivitis in guinea pigs

Kenneth J Mandell; Howard Wessel; Erika Klitsch; David Culp; Justin Prater; Brian C Gilger; Larry R Brown

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4361. doi:

ARVO Annual Meeting Abstract June 2017

Evaluation of Aflibercept in a Laser-Induced Model of Choroidal Neovascularization in Pigs

David Culp; Samirkumar Rajnikant Patel; Brian C Gilger

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1990. doi:

ARVO Annual Meeting Abstract June 2017

Modifications of Sunitinib-Loaded GB-102 Microparticles that Lengthen Drug Release: 9-Months Ocular Tolerability and PK in Rabbit Following IVT Dosing

Ming Yang; Ward Peterson; Yun Yu; Joshua Kays; Delia Cardona; David Culp; Brian C Gilger; David McKenzie; Abraham Anonuevo; Bryan Hoang; Connie Yu; Jeffrey Cleland

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4115. doi:

ARVO Annual Meeting Abstract September 2016

A 6-Week Ocular Pharmacokinetic Study of ENV905 (difluprednate) Intracameral Implant or Durezol in the Albino Rabbit

Rozemarijn S Verhoeven; RiLee Robeson; Andres Garcia; Brian C Gilger; David Culp; Craig B Struble; Lee Hamm; Thomas Grizzle; Tomas Navratil; Rhett M Schiffman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5711. doi:

ARVO Annual Meeting Abstract September 2016

Characterization of a quantitative model of corneal inflammation, wound healing, and fibrosis in the rabbit

David Culp; Elizabeth Schaefer; Maria-Grazia Spiga; Aliah Hackney; Nicholas Smith; Brian C Gilger

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1286. doi:

ARVO Annual Meeting Abstract September 2016

GB-102 for Wet AMD: A Novel Injectable Formulation that Safely Delivers Active Levels of Sunitinib to the Retina and RPE/Choroid for Over Four Months

Ming Yang; Ward M Peterson; Yun Yu; Joshua Kays; Delia Cardona; David Culp; Brian C Gilger; Jeffrey Cleland

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5037. doi:

Retinal Cell Biology February 2014

Targeting Müller Cell–Derived VEGF 164 to Reduce Intravitreal Neovascularization in the Rat Model of Retinopathy of Prematurity

PDF

Yanchao Jiang; Haibo Wang; David Culp; Zhihong Yang; Lori Fotheringham; John Flannery; Scott Hammond; Tal Kafri; M. Elizabeth Hartnett
TAGS: vascular endothelial growth factor a, retinopathy of prematurity, vitreous neovascularization
Invest. Ophthalmol. Vis. Sci.. 2014; 55(2):824-831. doi: 10.1167/iovs.13-13755

ARVO Annual Meeting Abstract April 2011

Targeting Mueller Cell-derived VEGF With Short Hairpin RNA

George W. Smith; W. David Culp, Jr.; Grace Byfield; Tal Kafri; John Flannery; Mary Elizabeth Hartnett

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4865. doi:

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

A Pilot Study to Evaluate Surgical Implantation of a Protein-Based Artificial Retina in a Rodent

Characterization of a Chronic Panuveitis Model in the Rabbit.

Chronic Model of Retinal Neovascularization (RNV) in New Zealand Red Rabbits.

Characterization of the Royal College of Surgeon’s Rat Model Endpoints for Use in Preclinical Ophthalmic Studies

Sunitinib-Loaded Injectable Polymer Depot Formulation for Potential Once per Year Treatment of Neovascular Age-related Macular Degeneration (wet AMD)

Activity of anti-Tissue Factor fusion protein ICON-1 in a swine model of choroidal neovascularization

ICON-1 Pharmacokinetics after intravitreal and intravenous administration to rabbits

Assessment of a pre-clinical model of phacoemulsification and aspiration of cataracts in rabbits

Episcleral sustained ocular delivery of bromfenac and brinzolamide

Characterization of a quantitative model of corneal transplantation in the rabbit

Effect of ST266, an amnion-derived multipotent progenitor cell-derived secretome, in a corneal incision model for post-operative inflammation

Anti-inflammatory effects of ST266, an amnion-derived multipotent progenitor cell-derived secretome, on corneal wound healing and stromal fibrosis in rabbits

Anti-allergic effects of ST266, an amnion-derived multipotent progenitor cell-secretome, in ovalbumin-induced allergic conjunctivitis in guinea pigs

Evaluation of Aflibercept in a Laser-Induced Model of Choroidal Neovascularization in Pigs

Modifications of Sunitinib-Loaded GB-102 Microparticles that Lengthen Drug Release: 9-Months Ocular Tolerability and PK in Rabbit Following IVT Dosing

A 6-Week Ocular Pharmacokinetic Study of ENV905 (difluprednate) Intracameral Implant or Durezol in the Albino Rabbit

Characterization of a quantitative model of corneal inflammation, wound healing, and fibrosis in the rabbit

GB-102 for Wet AMD: A Novel Injectable Formulation that Safely Delivers Active Levels of Sunitinib to the Retina and RPE/Choroid for Over Four Months

Targeting Müller Cell–Derived VEGF 164 to Reduce Intravitreal Neovascularization in the Rat Model of Retinopathy of Prematurity

Targeting Mueller Cell-derived VEGF With Short Hairpin RNA

To View More...

You must be signed into an individual account to use this feature.